Santa Cruz Biotechnology offers a broad range of Klebsiella Antibodies for the detection and analysis of Klebsiella species in various research applications. Klebsiella Antibodies are essential tools for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Klebsiella is a genus of bacteria known for its role in various infections, particularly in immunocompromised individuals. Studying Klebsiella has become increasingly critical due to its growing antibiotic resistance and significant impact on public health. Understanding the mechanisms of Klebsiella pathogenesis can lead to better therapeutic strategies and infection control measures. Researchers worldwide rely on high-quality monoclonal antibodies to advance their understanding of bacterial infections and host responses. Advanced research tools enable scientists to investigate bacterial virulence factors and host-pathogen interactions in greater detail. Klebsiella monoclonal antibodies from Santa Cruz Biotechnology empower researchers to make meaningful contributions to microbiological research and the development of new therapeutic approaches.